Intuitive Surgical: FY25 Q4 earnings call, Jan 22, 2026

Thu, Jan 22Earnings callSpeaker-labelled transcriptIntuitive Surgical

No Kalshi or Polymarket word markets were listed for Intuitive Surgical’s Jan 22, 2026 earnings call (FY25 Q4). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

3 matches for “FDA”; 3 quoted, at least 25 words apart.

David Rosacompanyprepared

…the clinical impact of Force Feedback at scale. This month, we received FDA clearance for several cardiac procedures on da Vinci 5 using non-Force Feedback…

David Rosacompanyprepared

…Turning to Ion. Worldwide procedures grew 51% to just over 144,000. Since FDA clearance in 2019, physicians have performed over 325,000 Ion procedures with a…

Travis Steedanalystqa

First, I wanted to ask about the FDA approval for the cardiac non-Force Feedback instruments. Just trying to get a little more color on what…

Agents: this page as TSV at /api/v1/appearances/intuitive-surgical:2026-01-22:earnings_call · words: /api/v1/brief?appearance=intuitive-surgical:2026-01-22:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP